The omicron variant of the coronavirus could lead to more infections among vaccinated people but they will most likely remain protected from a severe course of illness, according to the inventor of ...
Clinical Trials Arena on MSN
JPM26: BioNTech gears up for multiproduct oncology status by 2030
Set for multiple late-stage readouts in oncology in 2026, BioNTech is entering a crucial phase of its roadmap beyond Covid-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results